Study to Compare 2 Botulinum Type A Toxins in the Treatment of Glabellar Frown Lines

NCT04763265 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
208
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Croma-Pharma GmbH

Collaborators